chr17-40637555-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS2

The NM_003079.5(SMARCE1):​c.174G>A​(p.Thr58Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T58T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000018 ( 0 hom. )

Consequence

SMARCE1
NM_003079.5 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.730

Publications

0 publications found
Variant links:
Genes affected
SMARCE1 (HGNC:11109): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1) The protein encoded by this gene is part of the large ATP-dependent chromatin remodeling complex SWI/SNF, which is required for transcriptional activation of genes normally repressed by chromatin. The encoded protein, either alone or when in the SWI/SNF complex, can bind to 4-way junction DNA, which is thought to mimic the topology of DNA as it enters or exits the nucleosome. The protein contains a DNA-binding HMG domain, but disruption of this domain does not abolish the DNA-binding or nucleosome-displacement activities of the SWI/SNF complex. Unlike most of the SWI/SNF complex proteins, this protein has no yeast counterpart. [provided by RefSeq, Jul 2008]
SMARCE1 Gene-Disease associations (from GenCC):
  • familial meningioma
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, G2P, Ambry Genetics
  • Coffin-Siris syndrome 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Coffin-Siris syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial multiple meningioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.24).
BP6
Variant 17-40637555-C-T is Benign according to our data. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422. Variant chr17-40637555-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 463422.
BP7
Synonymous conserved (PhyloP=0.73 with no splicing effect.
BS2
High AC in GnomAdExome4 at 27 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCE1NM_003079.5 linkc.174G>A p.Thr58Thr synonymous_variant Exon 5 of 11 ENST00000348513.12 NP_003070.3 Q969G3-1A0A024R1S7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCE1ENST00000348513.12 linkc.174G>A p.Thr58Thr synonymous_variant Exon 5 of 11 1 NM_003079.5 ENSP00000323967.6 Q969G3-1
ENSG00000264058ENST00000476049.1 linkn.*599-1042G>A intron_variant Intron 7 of 12 5 ENSP00000463483.1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152102
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000239
AC:
6
AN:
251364
AF XY:
0.0000294
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000185
AC:
27
AN:
1461024
Hom.:
0
Cov.:
30
AF XY:
0.0000179
AC XY:
13
AN XY:
726848
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33432
American (AMR)
AF:
0.0000447
AC:
2
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26100
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86240
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53400
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000189
AC:
21
AN:
1111348
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152102
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41406
American (AMR)
AF:
0.00
AC:
0
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000564
Hom.:
0
Bravo
AF:
0.0000113
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial meningioma;C4310788:Coffin-Siris syndrome 5 Uncertain:1
Dec 12, 2022
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial meningioma Benign:1
Oct 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Feb 06, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.24
CADD
Benign
15
DANN
Benign
0.96
PhyloP100
0.73
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201976136; hg19: chr17-38793807; API